focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Innov Regulatory News (SEED)

Share Price Information for Seed Innov (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.05
Bid: 2.00
Ask: 2.10
Change: -0.10 (-4.65%)
Spread: 0.10 (5.00%)
Open: 2.15
High: 2.15
Low: 2.05
Prev. Close: 2.15
SEED Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Food Standard Agency’s Public List of CBD Products

5 Apr 2022 07:00

RNS Number : 2219H
Seed Innovations Limited
05 April 2022
 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

5 April 2022

SEED Innovations Limited ("SEED" or the "Company")

 Food Standard Agency's Public List of CBD Products Update

SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to note the recent update by the UK Food Standard Agency ('FSA') with a list of cannabidiol ('CBD') products permitted to stay on the market in England and Wales, pending further consideration.

A number of CBD products sold by some of SEED's portfolio companies, have successfully been included on the FSA's list of CBD products linked to novel food applications, enabling them to continue in the market and progress through the validation stage.

This follows a two-year cooperation between the FSA and the Association for the Cannabinoid Industry, the UK's CBD sector trade body.

Products from investee companies Yooma Wellness Inc. ('Yooma'), South West Brands Limited ('SWB'), and CiiTECH Limited ('CiiTECH') have been included in the update by the FSA.

Highlights

 

· Portfolio companies Yooma, SWB, and CiiTECH have featured on the FSA's list of CBD products that may stay on the market in England and Wales

· Products which appear on the list are linked to novel food applications which the FSA already validated or considered that are sufficiently progressing towards validation

· The UK becomes one of the first countries to regulate the sale of CBD products as foodstuff to consumers

 

 

Alfredo Pascual, VP of Investment Analysis of SEED, commented: "We are very encouraged to see the inclusion of a number of our investee companies' products within the FSA's public list of CBD products that may stay on the market in England and Wales. The hard work being carried out by our portfolio companies to meet the UK's legal and regulatory requirements indicates a high level of level of commitment to quality and safety, bringing much needed clarity to consumers. 

"We welcome regulatory certainty in the sector and look forward to further progress as the sector continues to establish itself."

 

Further information from the Food Standard Agency can be found at https://data.food.gov.uk/cbd-products/landing

***ENDS***

For further information on the Company please visit www.seedinnovations.co or contact:

 

 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Catherine Leftley

Isabelle Morris

St Brides Partners Ltd,

Financial PR

E: info@stbridespartners.co.uk

 

 

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAIIMFTMTAMBPT
Date   Source Headline
13th Oct 202312:01 pmRNSTransaction in Own Shares & TVR
12th Oct 20237:00 amRNSTransaction in Own Shares & TVR
11th Oct 20237:00 amRNSTransaction in Own Shares & TVR
10th Oct 202311:37 amRNSTransaction in Own Shares & TVR
9th Oct 20237:00 amRNSTransaction in Own Shares & TVR
6th Oct 20238:06 amRNSTransaction in Own Shares & TVR
5th Oct 20235:23 pmRNSTransaction in Own Shares & TVR
4th Oct 20237:00 amRNSTransaction in Own Shares & TVR
3rd Oct 20233:40 pmRNSTransaction in Own Shares & TVR
20th Sep 202311:00 amRNSResult of AGM
19th Sep 20236:00 pmRNSShare Buy-Back Programme
13th Sep 20235:34 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSPartial Sale of Avextra:60% Premium to Entry Point
8th Sep 202312:15 pmRNSInvestee Company Updates: Northern Leaf & OTO
7th Sep 202310:40 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Sep 20237:01 amRNSNotice of AGM & Investor Presentation
1st Sep 20237:00 amRNSAppointment of Executive Director
16th Aug 202311:00 amRNSInvestee Company Update: Little Green Pharma Ltd
14th Aug 20237:15 amRNSInvestee Company Update: Clean Food Group
8th Aug 20237:00 amRNSClean Food Group Update: Strategic Collaboration
3rd Aug 20237:00 amRNSInvestee Company Update: Portage Biotech Inc
3rd Aug 20237:00 amRNSInvestee Company Update: Little Green Pharma Ltd
28th Jul 20231:46 pmRNSInvestee Company Update: Little Green Pharma Ltd
12th Jul 20231:10 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th Jun 20232:38 pmRNSInvestee Company Update: Little Green Pharma Ltd
27th Jun 20237:00 amRNSFinal Results
12th Jun 20238:07 amRNSPortfolio Company Update: Northern Leaf Limited
1st Jun 20237:00 amRNSInvestee Company Update: Little Green Pharma Ltd
17th May 202312:50 pmRNSInvestee Company Update: Avextra
9th May 20231:37 pmRNSInvestee Company Update: Yooma Wellness Inc.
9th May 20239:45 amRNSInvestee Company Update: Little Green Pharma Ltd
27th Apr 202312:35 pmRNSInvestee Company Update: Little Green Pharma Ltd
24th Apr 20237:00 amRNSPortfolio Update: Northern Leaf CLN conversion
20th Apr 202310:01 amRNSSale of South West Brands to OTO for £6.2 million
17th Apr 202311:19 amRNSInvestee Company Update: Little Green Pharma LTD
11th Apr 20237:00 amRNSLeap Gaming Update – Offer Declared Unconditional
24th Mar 202311:04 amRNSInvestee Company Update: Little Green Pharma Ltd
22nd Mar 202310:26 amRNSInvestee Company Update: Little Green Pharma Ltd
22nd Mar 202310:25 amRNSInvestee Company Update: Little Green Pharma Ltd
15th Mar 202312:45 pmRNSAvextra AG Successfully Raises EUR 17 million
21st Feb 20237:00 amRNSPortfolio Company Update: South West Brands
15th Feb 202310:45 amRNSInvestee Company Update: Little Green Pharma Ltd
13th Feb 20233:00 pmRNSInvestee Company Update: Yooma Wellness Inc.
9th Feb 20237:15 amRNSInvestee Company Update: Avextra
6th Feb 20232:45 pmRNSInvestee Company Update: Little Green Pharma Ltd
16th Jan 20232:30 pmRNSInvestee Company Update: Little Green Pharma Ltd
4th Jan 20232:15 pmRNSDirector Share Purchase
15th Dec 20224:22 pmRNSDirector Share Purchase
14th Dec 20224:07 pmRNSDirector Share Purchases
12th Dec 20225:22 pmRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.